SeraNovo
SeraNovo is an innovative formulation company improving the oral bioavailability of active ingredients. The focus of the company is on solving the problem of poor drug solubility by designing DES formulations to increase the oral bioavailability when administered as a capsule or tablet. For each of these poorly soluble or high melting point API’s, a DES-based formulation is designed which is proven to increase the oral bioavailability substantially more than competing techniques. SeraNovo is a privately owned company located in Leiden, the Netherlands and as technology inventor owns all know-how and IP.
SeraNovo is an innovative formulation company improving the oral bioavailability of active ingredients. The focus of the company is on solving the problem of poor drug solubility by designing DES formulations to increase the oral bioavailability when administered as a capsule or tablet. For each of these poorly soluble or high melting point API’s, a DES-based formulation is designed which is proven to increase the oral bioavailability substantially more than competing techniques. SeraNovo is a privately owned company located in Leiden, the Netherlands and as technology inventor owns all know-how and IP.